Literature DB >> 15967615

Cerebrospinal fluid interleukin-6 levels in patients with West syndrome.

Hasan Tekgul1, Muzaffer Polat, Ayse Tosun, Gul Serdaroglu, Necil Kutukculer, Sarenur Gokben.   

Abstract

Elevated cytokine response has been reported in patients with epileptic seizures. The objective of this study was to investigate the possible role of interleukin-6 (IL-6) in the pathogenesis of infantile spasms in West syndrome (WS). We measured IL-6 levels in cerebrospinal fluid (CSF) obtained from the newly diagnosed patients with WS. Twelve patients with WS (Group I) were classified as symptomatic WS (Group IA) in eight and as cryptogenic WS (Group IB) in four. The results were compared with control groups including patients with tonic-clonic seizures associated with two different kind of inflammation of central nervous system; Group IIA (infection): bacterial meningitis/encephalitis and Group IIB (trauma): post-traumatic seizures. There was no statistically significant difference between the mean values of CSF IL-6 levels in patients with WS (2.95 +/- 2.31 pg/ml) and those of subgroups of WS (Group IA: 2.26 +/- 2.01 pg/ml and Group IB: 4.33 +/- 2.52 pg/ml). Both control groups had highly increased IL-6 levels in CSF (Group IIA: 193.05 +/- 185.52 pg/ml and Group IIB: 112.74 +/- 167.44 pg/ml) than those of the patients with WS. Elevated IL-6 response in patients with tonic-clonic seizures associated with inflammation of central nervous system might be due to the seizures themselves or related to the underling etiology (infection or trauma). However, no elevated IL-6 response was found in patients with infantile spasms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967615     DOI: 10.1016/j.braindev.2005.03.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

Review 1.  Infantile spasms: review of the literature and personal experience.

Authors:  Alberto Fois
Journal:  Ital J Pediatr       Date:  2010-02-08       Impact factor: 2.638

Review 2.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

Review 3.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  Immune-mediated epilepsies.

Authors:  Tiziana Granata; Helen Cross; William Theodore; Giuliano Avanzini
Journal:  Epilepsia       Date:  2011-05       Impact factor: 5.864

5.  IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy.

Authors:  Antonio Leo; Valentina Nesci; Martina Tallarico; Nicola Amodio; Eugenia M Gallo Cantafio; Giovambattista De Sarro; Andrew Constanti; Emilio Russo; Rita Citraro
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

6.  Hyper-excitability and epilepsy generated by chronic early-life stress.

Authors:  Céline M Dubé; Jenny Molet; Akanksha Singh-Taylor; Autumn Ivy; Pamela M Maras; Tallie Z Baram
Journal:  Neurobiol Stress       Date:  2015

Review 7.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

8.  Involvement of Peripheral Monocytes with IL-1β in the Pathogenesis of West Syndrome.

Authors:  Tomoko Takamatsu; Gaku Yamanaka; Koko Ohno; Kanako Hayashi; Yusuke Watanabe; Mika Takeshita; Shinji Suzuki; Shinichiro Morichi; Soken Go; Yu Ishida; Shingo Oana; Yasuyo Kashiwagi; Hisashi Kawashima
Journal:  J Clin Med       Date:  2022-01-16       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.